On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes ...

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments wanes and Donald Trump’s tariff and price-cut threats weigh on the ...

Eli Lilly recently spoke out against proposed tariffs on pharmaceuticals, warning they could increase drug costs and restrict patient access. The drugmaker said it has invested more than $50 billion ...

Weight-loss jab users in Kent who rely on the "life-changing" treatment have voiced alarm about rising costs. Kayleigh ...

Major tech-heavy indices edged lower from record highs by midday Friday in New York, as investors adopted a cautious stance ...